Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Agilent, BG Medicine, and More

Premium

Agilent has named Lars Holmkvist as a senior vice president and president of its Diagnostics and Genomics group.

Holmkvist was president and CEO of diagnostic developer Dako, which Agilent acquired in June. He joined Dako from Applied Biosystems, and previously was at Medtronic Vascular and Cardiac Surgery.


BG Medicine said this week that it has appointed Howard Rosen as vice president of sales and marketing and Thomas Mortensen as vice president of European sales and marketing.

Rosen formerly was director of Boston Scientific's cardiovascular service line franchise and Mortensen was vice president of market development in Europe for Circulite and an international marketing director for EV3.

In a filing with the US Securities and Exchange Commission, BG Medicine also said that Chief Commercial Officer Stephen Miller's contract has been terminated, but that he will continue to serve as a consultant with the company on an interim basis.


Chemobio Diagnostics has appointed Sharon Klugewicz vice president of quality assurance/quality control and technical operations.

Previously Klugewicz was senior vice president of scientific and laboratory services at Pall.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.